[关键词]
[摘要]
阐述我国药品审评改革中药品技术转让政策带来的思考。分析药品注册申请过程中,科研机构、高校、企业等主体各阶段转让时机与策略的选择与面临的风险和利益。建议科研机构、高校、企业等各主体应结合政策、市场与自身特点选择适当的转让时机与策略。
[Key word]
[Abstract]
The thought of drugs technology transfer policies in the drug review system reform of China was elaborated. The drug registration application process was analyzed, the risks and benefits were gained by research institutes, universities, enterprises, and other stage selection in the pharmaceutical technology transfer timing. Scientific research institutions, universities, and enterprises should be combined with policies and market of their own characteristics and the appropriate timing and transfer policy were selected.
[中图分类号]
[基金项目]
2014年度黑龙江省社会科学研究规划年度项目(14B017);2014年度黑龙江省应用技术研究与开发计划项目(GB14D410)。